Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 13 news outlets
twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 9 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 814 followers.

Lovelace_Biomed: We’ve recently published an article on our latest research into improved NTM, pulmonary nontuberculous mycobacteria infection, treatment and therapy using inhaled formulation! ➡️ Read here: https://t.co/B6tZe1rL9G https://t.co/mWqI1bQoBi

20 Feb 2023

Reply Repost Favourite

We’ve recently published an article on our latest research into improved NTM, pulmonary nontuberculous mycobacteria infection, treatment and therapy using inhaled formulation! ➡️ Read here: https://t.co/tNCGaWyBKL https://t.co/KMjxjXZRSd

20 Feb 2023

Reply Repost Favourite

RT @NTM_papers: NTM-NET courtesy: Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary…

19 Jan 2023

Reply Repost Favourite

NTM-NET courtesy: Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection https://t.co/R40Y2fYega

18 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.